vs

Side-by-side financial comparison of FRIEDMAN INDUSTRIES INC (FRD) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $168.0M, roughly 1.2× FRIEDMAN INDUSTRIES INC). REPLIGEN CORP runs the higher net margin — 6.7% vs 1.8%, a 4.9% gap on every dollar of revenue. On growth, FRIEDMAN INDUSTRIES INC posted the faster year-over-year revenue change (78.6% vs 13.6%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $-6.3M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 13.3%).

Hellman & Friedman (H&F) is an American private equity firm founded in 1984 by Warren Hellman and Tully Friedman that makes investments primarily through leveraged buyouts as well as growth capital investments. It has focused its efforts on several core target industries including media, financial services, professional services and information services.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

FRD vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.2× larger
RGEN
$197.9M
$168.0M
FRD
Growing faster (revenue YoY)
FRD
FRD
+64.9% gap
FRD
78.6%
13.6%
RGEN
Higher net margin
RGEN
RGEN
4.9% more per $
RGEN
6.7%
1.8%
FRD
More free cash flow
RGEN
RGEN
$23.9M more FCF
RGEN
$17.6M
$-6.3M
FRD
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
13.3%
FRD

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
FRD
FRD
RGEN
RGEN
Revenue
$168.0M
$197.9M
Net Profit
$3.0M
$13.3M
Gross Margin
2.3%
52.5%
Operating Margin
2.3%
9.0%
Net Margin
1.8%
6.7%
Revenue YoY
78.6%
13.6%
Net Profit YoY
364.1%
143.9%
EPS (diluted)
$0.43
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRD
FRD
RGEN
RGEN
Q4 25
$168.0M
$197.9M
Q3 25
$152.4M
$188.8M
Q2 25
$134.8M
$182.4M
Q1 25
$169.2M
Q4 24
$94.1M
$174.1M
Q3 24
$106.8M
$154.9M
Q2 24
$114.6M
$154.1M
Q1 24
$151.3M
Net Profit
FRD
FRD
RGEN
RGEN
Q4 25
$3.0M
$13.3M
Q3 25
$2.2M
$14.9M
Q2 25
$5.0M
$14.9M
Q1 25
$5.8M
Q4 24
$-1.2M
$-30.3M
Q3 24
$-675.0K
$-654.0K
Q2 24
$2.6M
$3.3M
Q1 24
$2.1M
Gross Margin
FRD
FRD
RGEN
RGEN
Q4 25
2.3%
52.5%
Q3 25
1.9%
53.2%
Q2 25
5.2%
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
-0.2%
50.0%
Q2 24
-1.2%
49.8%
Q1 24
49.5%
Operating Margin
FRD
FRD
RGEN
RGEN
Q4 25
2.3%
9.0%
Q3 25
1.9%
8.9%
Q2 25
5.2%
7.6%
Q1 25
3.9%
Q4 24
-1.3%
-17.7%
Q3 24
-0.2%
-5.1%
Q2 24
-1.2%
1.0%
Q1 24
1.3%
Net Margin
FRD
FRD
RGEN
RGEN
Q4 25
1.8%
6.7%
Q3 25
1.5%
7.9%
Q2 25
3.7%
8.2%
Q1 25
3.4%
Q4 24
-1.2%
-17.4%
Q3 24
-0.6%
-0.4%
Q2 24
2.2%
2.2%
Q1 24
1.4%
EPS (diluted)
FRD
FRD
RGEN
RGEN
Q4 25
$0.43
$0.24
Q3 25
$0.32
$0.26
Q2 25
$0.71
$0.26
Q1 25
$0.10
Q4 24
$-0.17
$-0.55
Q3 24
$-0.10
$-0.01
Q2 24
$0.37
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRD
FRD
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$3.0M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$142.2M
$2.1B
Total Assets
$311.9M
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRD
FRD
RGEN
RGEN
Q4 25
$3.0M
$767.6M
Q3 25
$4.6M
$748.7M
Q2 25
$2.1M
$708.9M
Q1 25
$697.2M
Q4 24
$1.1M
$757.4M
Q3 24
$2.5M
$784.0M
Q2 24
$4.1M
$809.1M
Q1 24
$780.6M
Total Debt
FRD
FRD
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
FRD
FRD
RGEN
RGEN
Q4 25
$142.2M
$2.1B
Q3 25
$139.3M
$2.1B
Q2 25
$137.3M
$2.1B
Q1 25
$2.0B
Q4 24
$127.3M
$2.0B
Q3 24
$128.8M
$2.0B
Q2 24
$129.7M
$2.0B
Q1 24
$2.0B
Total Assets
FRD
FRD
RGEN
RGEN
Q4 25
$311.9M
$2.9B
Q3 25
$311.3M
$2.9B
Q2 25
$219.1M
$2.9B
Q1 25
$2.9B
Q4 24
$210.3M
$2.8B
Q3 24
$209.2M
$2.8B
Q2 24
$222.8M
$2.9B
Q1 24
$2.8B
Debt / Equity
FRD
FRD
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRD
FRD
RGEN
RGEN
Operating Cash FlowLast quarter
$-4.7M
$25.7M
Free Cash FlowOCF − Capex
$-6.3M
$17.6M
FCF MarginFCF / Revenue
-3.8%
8.9%
Capex IntensityCapex / Revenue
1.0%
4.1%
Cash ConversionOCF / Net Profit
-1.56×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRD
FRD
RGEN
RGEN
Q4 25
$-4.7M
$25.7M
Q3 25
$434.0K
$48.1M
Q2 25
$15.5M
$28.6M
Q1 25
$15.0M
Q4 24
$39.2M
Q3 24
$49.3M
Q2 24
$-6.1M
$42.2M
Q1 24
$44.7M
Free Cash Flow
FRD
FRD
RGEN
RGEN
Q4 25
$-6.3M
$17.6M
Q3 25
$-2.0M
$43.4M
Q2 25
$13.7M
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$-7.1M
$37.4M
Q1 24
$36.4M
FCF Margin
FRD
FRD
RGEN
RGEN
Q4 25
-3.8%
8.9%
Q3 25
-1.3%
23.0%
Q2 25
10.2%
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
-6.2%
24.3%
Q1 24
24.0%
Capex Intensity
FRD
FRD
RGEN
RGEN
Q4 25
1.0%
4.1%
Q3 25
1.6%
2.5%
Q2 25
1.3%
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
0.9%
3.1%
Q1 24
5.5%
Cash Conversion
FRD
FRD
RGEN
RGEN
Q4 25
-1.56×
1.93×
Q3 25
0.19×
3.23×
Q2 25
3.08×
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
-2.36×
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FRD
FRD

Prime Coil$152.0M90%
Manufactured Pipe$14.9M9%
Customer Owned$1.1M1%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons